Capitol Health Future Growth

Future criteria checks 4/6

Capitol Health is forecast to grow earnings and revenue by 38.7% and 5.5% per annum respectively. EPS is expected to grow by 37.9% per annum. Return on equity is forecast to be 11.6% in 3 years.

Key information

38.7%

Earnings growth rate

37.9%

EPS growth rate

Healthcare earnings growth19.9%
Revenue growth rate5.5%
Future return on equity11.6%
Analyst coverage

Good

Last updated21 Mar 2024

Recent future growth updates

Recent updates

Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Jan 15
Capitol Health Limited's (ASX:CAJ) Popularity With Investors Is Clear

Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Dec 15
Capitol Health (ASX:CAJ) Takes On Some Risk With Its Use Of Debt

Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Oct 22
Is Capitol Health Limited (ASX:CAJ) Worth AU$0.3 Based On Its Intrinsic Value?

Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

May 28
Capitol Health (ASX:CAJ) Seems To Use Debt Rather Sparingly

Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Apr 16
Should You Investigate Capitol Health Limited (ASX:CAJ) At AU$0.37?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Mar 05
Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Feb 14
Have Insiders Been Selling Capitol Health Limited (ASX:CAJ) Shares This Year?

Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Jan 19
Did You Miss Capitol Health's (ASX:CAJ) 20% Share Price Gain?

Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Dec 22
Is Capitol Health Limited's (ASX:CAJ) Shareholder Ownership Skewed Towards Insiders?

Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Dec 01
Capitol Health Limited's (ASX:CAJ) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?

Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Aug 17
Here's Why We Don't Think Capitol Health's (ASX:CAJ) Statutory Earnings Reflect Its Underlying Earnings Potential

Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Jul 25
Is Now An Opportune Moment To Examine Capitol Health Limited (ASX:CAJ)?

Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Jul 04
Is Capitol Health Limited's (ASX:CAJ) Latest Stock Performance A Reflection Of Its Financial Health?

Earnings and Revenue Growth Forecasts

ASX:CAJ - Analysts future estimates and past financials data (AUD Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
6/30/20262661714476
6/30/20252531415436
6/30/202423888336
12/31/202322961236N/A
9/30/2023219-31637N/A
6/30/2023210-112138N/A
3/31/2023198-121933N/A
12/31/2022187-121628N/A
9/30/2022186-11830N/A
6/30/2022184111932N/A
3/31/2022186122234N/A
12/31/2021188142636N/A
9/30/2021183132939N/A
6/30/2021178123341N/A
3/31/202116883343N/A
12/31/202015943445N/A
9/30/202015632840N/A
6/30/202015412335N/A
3/31/202015681830N/A
12/31/2019157151225N/A
9/30/201915320822N/A
6/30/201914924418N/A
12/31/2018137-2515N/A
9/30/2018128-6413N/A
6/30/2018119-11411N/A
12/31/20171102715N/A
9/30/20171082N/A15N/A
6/30/20171072N/A15N/A
12/31/2016801N/A13N/A
9/30/2016922N/A13N/A
6/30/20161042N/A13N/A
3/31/2016148-2N/A15N/A
12/31/20151391N/A13N/A
9/30/20151253N/A14N/A
6/30/20151104N/A16N/A
3/31/20151036N/A16N/A
12/31/2014959N/A16N/A
9/30/2014928N/A14N/A
6/30/2014907N/A12N/A
3/31/2014836N/A10N/A
12/31/2013775N/A7N/A
9/30/2013704N/A7N/A
6/30/2013624N/A6N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: CAJ's forecast earnings growth (38.7% per year) is above the savings rate (2.2%).

Earnings vs Market: CAJ's earnings (38.7% per year) are forecast to grow faster than the Australian market (13.2% per year).

High Growth Earnings: CAJ's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: CAJ's revenue (5.5% per year) is forecast to grow faster than the Australian market (4.6% per year).

High Growth Revenue: CAJ's revenue (5.5% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: CAJ's Return on Equity is forecast to be low in 3 years time (11.6%).


Discover growth companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.